Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.

Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- CheckyesterdayChange DetectedRevision tag on the page updated to v3.5.5, replacing the previous v3.5.4. This indicates a new build/revision label without altering the available content or functionality.SummaryDifference0.0%

- Check8 days agoChange DetectedA new publication citation by Tang et al. was added to the Publications section, describing amivantamab plus chemotherapy versus chemotherapy for EGFR Exon 20 insertion NSCLC in a Chinese mainland subgroup analysis of the PAPILLON trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew May 2026 revision entries were added and the page version updated to v3.5.4, while April 2026 entries and the previous v3.5.3 revision were removed; this reflects a versioning update rather than substantive study information.SummaryDifference0.1%

- Check36 days agoChange DetectedThe revision label on the page was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content. This signals a minor update to the study record, typically involving small edits or fixes without changing the underlying data.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study location list was updated to 232 sites with new entries including Zhejiang University’s Second Affiliated Hospital (Hangzhou), Hunan Cancer Hospital, Beijing Cancer Hospital, and The Royal Marsden locations; references to 229 sites were removed.SummaryDifference0.3%

- Check72 days agoChange DetectedStudy locations were updated: City of Hope was removed and City of Hope 2 was added. This affects where participants can enroll and which sites are available for the study.SummaryDifference0.1%

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.